The S-Series OCT device is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization, with image review manipulation software for identifying and annotating regions of interest.
The device has a general indication and is not specifically indicated for use in any tissue type.
Participating Clinical Trial Sites using B-Series OCT
These providers are participating in a randomized, controlled clinical trial to evaluate Perimeter’s investigational B-Series OCT* with AI against the standard of care when used in breast lumpectomy procedures.
Florida
Baptist MD Anderson Cancer Center
Jacksonville, FL
Dr. Laila Samiian, Dr. Karen Ching-Tismal, and
Dr. Cathryn Johnson
Mayo Clinic
Jacksonville, FL
Dr. James Jakub and Dr. Sarah McLaughlin
Moffitt Cancer Center
Tampa, FL
Dr. Marie Lee, Dr. Brian Czerniecki, and Dr. Laura Kruper
Pennsylvania
MD Anderson Cancer Center at Cooper in partnership with Redeemer Health
Meadowbrook, PA
Dr. Stacy Krisher, Dr. Anna Mazor, and Dr. Malini lyer* *Patient enrollment for Dr. Malini Iyer is currently closed.
Tennessee
WEST Cancer Center & Research Institute
Germantown, TN
Dr. Richard Fine, Dr. Michael Berry, and Dr. Richard Gilmore Patient enrollment for site is currently closed.
Baylor College of Medicine
Houston, TX
Dr. Alastair Thompson, Dr. Elizabeth Bonefas, and
Dr. Stacey Carter Patient enrollment for site is currently closed.
Medical City Healthcare Dallas, TX
Dr. Allison DiPasquale
Methodist Healthcare
San Antonio, TX
Dr. Maryam Elmi
Washington
University of Washington/Fred Hutchinson Cancer Center
Seattle, WA
Dr. Meghan R. Flanagan, Dr. Emily Palmquist, Dr. Sara Javid, and Dr. Kristine E. Calhoun
Wisconsin
University of Wisconsin
Madison, WI
Dr. Lee Wilke and Dr. Meeghan Lautner
*The Perimeter B-Series OCT System is an adjunctive three-dimensional imaging tool which provides volumetric cross-sectional, real-time depth visualization, coupled with an artificial intelligence computer aided detection algorithm which identifies and marks focal areas suspicious for breast cancer and is used concurrently with physician interpretation of the images. Selene is intended for use in conjunction with other standard methods for evaluation of the margins of an excised lumpectomy specimen during surgical procedures in patients with a biopsy-confirmed diagnosis of breast cancer.
Perimeter B-Series OCT is not available for sale in the United States. CAUTION – Investigational device. Limited by U.S. law to investigational use.
What Patients Are Saying
Moving beyond surgery gets you back to doing the things you love
Nadia
Nadia shares her journey with breast cancer and infertility, as well as her treatment plan with Perimeter's technology.
Mary
Mary discusses her breast cancer diagnosis and involvement in a clinical trial using Perimeter’s technology.
Jessie
Jessie discusses her breast cancer diagnosis and involvement in a clinical trial using Perimeter’s technology.
Suzanne
Hear Suzanne talk about the fear she experienced with her cancer diagnosis and being called back for a second surgery.
Jenn
Jenn describes how her battle with cancer affected her outlook on life.
Jenn
Jenn’s year-long cancer journey included repeat surgeries to remove all of the cancer, resulting in delayed treatment and emotional trauma.
